Zambon SpA
Privately held: no public share price
Assets
(3 total)
3Total Assets
2Approved
0Phase 3 / Filed
1Phase 1–2 / Early
3Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Approved | dopamine precursorSmall molecule | Parkinson's Disease | |
Safinamide(Xadago) | Approved | MAO-BSmall molecule | Parkinson's Disease |
Voriconazole (ZP-059)No recent activity | Phase 1 | fungal CYP51 / lanosterol 14-alpha-demethylaseSmall molecule | AsthmaAllergic Bronchopulmonary Aspergillosis |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.